Eric A. Rose

Dr. Rose became a member of Orchestra BioMed’s Board of Directors in December 2018. He previously served as a Strategic Advisor since July 2018.

Dr. Rose is Executive Chairman of the Board of Directors of SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on serious unmet medical needs and biothreats. Previously, he had served as Chairman and CEO of SIGA. Dr. Rose chaired the Department of Health Evidence & Policy at the Mount Sinai School of Medicine from 2008 to 2012. From 1994 through 2007, he served as Chairman of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital. In addition to his roles at SIGA, Dr. Rose holds a position as Executive Vice President – Life Sciences at MacAndrews & Forbes Incorporated, the holding company of Ronald O. Perelman and a related party to SIGA. In April 2013, he became a director for Mesoblast Inc. (NASDAQ: MESO), an advanced cellular medicine company, where he serves as chairman of the scientific and technology committee. In 2015, Dr. Rose became a director of Abiomed, Inc. (NASDAQ: ABMD), a leading provider of medical devices that provide circulatory support.